Skip to main content
Fig. 5 | EJNMMI Research

Fig. 5

From: Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [18F]DCFPyL-PET: comparison to [18F]fluorocholine-PET

Fig. 5

Axial CT image (a), axial [18F]DCFPyL SUV map (range 0–10.0 g/mL) superimposed on CT (b), coronal [18F]DCFPyL PET (range 0–10.0 g/mL) (c), Ki parametric map (d), k4 parametric map (e) and localized tumour in red using the classifier from logistic regression (f), in a 64-year-old man with PCa (Gleason score 7 (3 + 4)). Pre-op PSA was 8.17 ng/mL. Mean SUV of the tumour ROI was 13.4 g/mL. CT, computed tomography; DCFPyL, 2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid; SUV, standardized uptake value; PET, positron emission tomography; Ki, net uptake rate constant from plasma; k4, dissociation rate constant; PCa, prostate cancer; PSA, prostate-specific antigen; ROI, region of interest

Back to article page